<DOC>
	<DOCNO>NCT02215694</DOCNO>
	<brief_summary>The purpose study evaluate effect dual probiotic strain contain Lactobacillus curvatus HY7601 Lactobacillus plantarum KY1032 triglyceride apolipoprotein A-V .</brief_summary>
	<brief_title>Supplementation Dual Probiotic Strains Reduced Fasting Triglyceride Enhanced Apolipoprotein A-V Levels</brief_title>
	<detailed_description>A randomized , double-blind , placebo-controlled study conduct 128 nondiabetic hypertriglyceridemic ( Plasma Triglyceride , 150-500 mg/dL ) subject . Over 12 week test period , probiotic group consume 2g powder daily contain dual probiotic strain , placebo group consume without probiotic .</detailed_description>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>nondiabetic ( plasma fasting glucose , &lt; 126mg/dL ; 2hour plasma glucose , &lt; 200mg/dL ) borderline moderate hypertriglyceridemia ( plasma triglyceride , 150500 mg/dL ) lipidlowering medication use medication supplement use probiotic product use past 1 month dyslipidemia diabetes mellitus hypertension liver disease renal disease cardiovascular disease cerebrovascular disease pancreatitis cancer medication alcohol abuse pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>24 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Apolipoprotein A-V</keyword>
	<keyword>LDL particle size</keyword>
	<keyword>probiotic</keyword>
	<keyword>triglyceride</keyword>
</DOC>